Vetoquinol - Drontal Gatti 8 tablets

Name:  Drontal Tablets (cats)

Category:  Antehelmintics

Active ingredients:  Praziquantel 20 mg and pyrantel embonate 230 mg

Excipients:  Maize starch, microcrystalline cellulose, polyvidone, magnesium stearate, colloidal anhydrous silica, hydroxypropyl methylcellulose, pPolyethylene glycol 4000, titanium dioxide

Pharmaceutical form: Blister

Container: Tablets

Target species: Cats

Directions: Treatment of mixed nematode and tapeworm infestations in cats, caused by: Ascarids (Toxocara cati syn. mystax, Toxascaris leonina); Hookworms (Ancylostoma tubaeforme, Ancylostoma braziliense); Tapeworms (Echinococcus granulosus, Echinococcus multilocularis, Dipylidium caninum, Taenia spp., Mesocestoides spp., Joyeuxiella spp.).

Contraindications: Do not use in animals with known hypersensitivity to the active substances or to any of the excipients. It should not be used during pregnancy. Do not use in kittens under 4 weeks of age. Do not use concurrently with piperazine-based compounds.

Undesirable effects:  None known.

Use during pregnancy, lactation or lay:  Must not be used during pregnancy.

Interaction with other medicinal products and other forms of interaction:  None known.

Dosage and administration route:  The dose is 5 mg praziquantel and 57.5 mg pyrantelembonate per kg body weight. This corresponds to 1 tablet per 4 kg body weight. The tablet may be divided as necessary. The tablets are administered directly or by wrapping them in a piece of meat or sausage or by crushing them with the feed. No dietary measures are necessary. They are used in a single solution.

Overdose (symptoms, emergency procedures, antidotes) if necessary: ​​ In order to achieve effective parasite control, treatment should be carried out based on the results of the parasitological examination. To ensure correct dosage, animals should be weighed. Since tapeworm infestation in cats does not appear before the 3rd week of life, treatment with the drug is only indicated after the 3rd week of life. Resistance of parasites to a particular class of anthelmintics may develop following frequent, repeated use of an anthelmintic of the same class. Echinococcosis represents a danger to humans. In the case of echinococcosis, specific guidelines for treatment and follow-up and for the protection of people must be followed. Do not use in severely debilitated animals or with severely impaired liver or kidney function. Special precautions to be taken by the person administering the product to animals: People with known hypersensitivity to the active substances contained in this medicinal product should administer the product with caution. Wash hands after use. Avoid contact with eyes. In case of eye irritation, seek medical advice. Do not eat, drink or smoke while using the product. Overdose: symptoms of overdose are not evident with doses up to 5 times the recommended dose. The first expected symptom of intoxication is vomiting.

Wait time: Not applicable.

Preservation: This medicinal product does not require any special storage conditions.